Dhingra Ankur (CIK 0001849682)

Latest company ownership

Shares held
354,958
Last filed at
Mar 27, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
30,000
Last filed at
Mar 25, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
24,906
Last filed at
May 14, 2025
Confidence Score
52.2
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 12, 2025 May 14, 2025 ILLUMINA, INC. CFO Buy 97.5 +6,100 32.44% $495.4K
Mar 26, 2024 Mar 27, 2024 Summit Therapeutics Inc. CFO Buy 97.5 +100,000 39.22% $375K
Dec 13, 2023 Dec 13, 2023 Summit Therapeutics Inc. CFO Buy 86.3 +20,400 8.70% $44.3K
Mar 7, 2023 Mar 8, 2023 Summit Therapeutics Inc. CFO Buy 95.0 +196,362 252.64% $206.2K
Aug 16, 2022 Mar 8, 2023 Summit Therapeutics Inc. CFO Buy 91.3 +37,685 94.12% $36.6K
Aug 16, 2022 Aug 17, 2022 Summit Therapeutics Inc. CFO Buy 91.3 +36,215 90.45% $35.1K
Mar 25, 2022 Mar 28, 2022 CareDx, Inc. CFO Sell 46.3 -1,254 -3.18% $47.5K
Nov 24, 2021 Nov 29, 2021 CareDx, Inc. CFO Buy 95.0 +5,000 34.48% $211.7K